Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

The medical device development ecosystem: Current regulatory state and challenges for future development: A review.

PMID: 37778922 ·

D, a, v, i, d, , R, , H, o, l, m, e, s, ;, , A, n, d, r, e, w, , F, a, r, b, ;, , N, a, b, i, l, , D, i, b, ;, , L, o, u, i, s, , J, a, c, q, u, e, s, ;, , S, t, a, n, t, o, n, , R, o, w, e, ;, , A, n, t, h, o, n, y, , D, e, M, a, r, i, a, ;, , S, p, e, n, c, e, r, , K, i, n, g, ;, , B, r, a, m, , Z, u, c, k, e, r, m, a, n

RevistaCardiovascular revascularization medicine : including molecular interventions
Año
PMID37778922

Resumen

There has been increasing emphasis on the development of new technology to mitigate unmet clinical needs in cardiovascular disease. This emphasis results in part from recognition that many devices, although being initially developed in the United States, were studied, and then eventually approved abroad before being returned to the U.S. for clinical application. The FDA (Food and Drug Administration) guidance document on Early Feasibility Studies (EFS) and then the 21st Century Cures Act from 20

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑